IRIS Accounts Production v22.1.4.3 07441542 Board of Directors 1.12.20 30.11.21 30.11.21 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure074415422020-11-30074415422021-11-30074415422020-12-012021-11-30074415422019-11-30074415422019-12-012020-11-30074415422020-11-3007441542ns16:EnglandWales2020-12-012021-11-3007441542ns15:PoundSterling2020-12-012021-11-3007441542ns11:Director12020-12-012021-11-3007441542ns11:PrivateLimitedCompanyLtd2020-12-012021-11-3007441542ns11:SmallEntities2020-12-012021-11-3007441542ns11:AuditExempt-NoAccountantsReport2020-12-012021-11-3007441542ns11:SmallCompaniesRegimeForDirectorsReport2020-12-012021-11-3007441542ns11:SmallCompaniesRegimeForAccounts2020-12-012021-11-3007441542ns11:AbridgedAccounts2020-12-012021-11-3007441542ns11:OrdinaryShareClass12020-12-012021-11-3007441542ns11:Director22020-12-012021-11-3007441542ns11:RegisteredOffice2020-12-012021-11-3007441542ns6:CurrentFinancialInstruments2021-11-3007441542ns6:CurrentFinancialInstruments2020-11-3007441542ns6:ShareCapital2021-11-3007441542ns6:ShareCapital2020-11-3007441542ns6:RetainedEarningsAccumulatedLosses2021-11-3007441542ns6:RetainedEarningsAccumulatedLosses2020-11-3007441542ns6:ComputerEquipment2020-12-012021-11-3007441542ns11:OrdinaryShareClass12021-11-30
REGISTERED NUMBER: 07441542 (England and Wales)












Financial Statements

for the Year Ended 30 November 2021

for

Haematology Medical Services Limited

Haematology Medical Services Limited (Registered number: 07441542)






Contents of the Financial Statements
for the Year Ended 30 November 2021




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 3


Haematology Medical Services Limited

Company Information
for the Year Ended 30 November 2021







DIRECTORS: Dr H N Ahmad
Mrs S O Ahmad





REGISTERED OFFICE: 3 Charnwood Street
Derby
DE1 2GY





REGISTERED NUMBER: 07441542 (England and Wales)





ACCOUNTANTS: Bourne & Co.
Chartered Accountants
3 Charnwood Street
Derby
Derbyshire
DE1 2GY

Haematology Medical Services Limited (Registered number: 07441542)

Abridged Balance Sheet
30 November 2021

2021 2020
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,555 560

CURRENT ASSETS
Debtors 156 156
Cash at bank 93,806 64,930
93,962 65,086
CREDITORS
Amounts falling due within one year 20,397 13,750
NET CURRENT ASSETS 73,565 51,336
TOTAL ASSETS LESS CURRENT
LIABILITIES

75,120

51,896

PROVISIONS FOR LIABILITIES 296 107
NET ASSETS 74,824 51,789

CAPITAL AND RESERVES
Called up share capital 5 100 100
Retained earnings 74,724 51,689
SHAREHOLDERS' FUNDS 74,824 51,789

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2021 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 30 November 2021 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 August 2022 and were signed on its behalf by:





Dr H N Ahmad - Director


Haematology Medical Services Limited (Registered number: 07441542)

Notes to the Financial Statements
for the Year Ended 30 November 2021

1. STATUTORY INFORMATION

Haematology Medical Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is represented by the sale of services provided excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Financial assets and liabilities
Short term debtors are measured at transaction price, less any impairment.

Short term creditors are measured at transaction price, less any impairment.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2020 - 3 ) .

Haematology Medical Services Limited (Registered number: 07441542)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2021

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 December 2020 2,533
Additions 2,145
Disposals (2,391 )
At 30 November 2021 2,287
DEPRECIATION
At 1 December 2020 1,973
Charge for year 644
Eliminated on disposal (1,885 )
At 30 November 2021 732
NET BOOK VALUE
At 30 November 2021 1,555
At 30 November 2020 560

5. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2021 2020
value: £    £   
100 Ordinary £1 100 100